Skip to Main Content

Author Details

Filip Roudnicky
F. Hoffmann-La Roche Ltd.
2012
22
13
PMIDPaper TitleJournal TitlePublished Year
35451764Preventing VEGF-Mediated Vascular Permeability by Experimentally Potentiating BBB Characteristics in Endothelial Cells.Methods Mol Biol2022
33711266Decoding Neuronal Diversification by Multiplexed Single-cell RNA-Seq.Stem Cell Reports2021
32127614Identification of a combination of transcription factors that synergistically increases endothelial cell barrier resistance.Sci Rep2020
32759214Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.Proc Natl Acad Sci U S A2020
32619513Patient hiPSCs Identify Vascular Smooth Muscle Arylacetamide Deacetylase as Protective against Atherosclerosis.Cell Stem Cell2020
32585158Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling.Am J Pathol2020
32442401Functional Genomics for Cancer Drug Target Discovery.Cancer Cell2020
32413331Patient hiPSCs Identify Vascular Smooth Muscle Arylacetamide Deacetylase as Protective against Atherosclerosis.Cell Stem Cell2020
31124101Monolayer Generation of Vascular Endothelial Cells from Human Pluripotent Stem Cells.Methods Mol Biol2019
31835296Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype.Int J Mol Sci2019
31553577Cellular Resistance Mechanisms to Targeted Protein Degradation Converge Toward Impairment of the Engaged Ubiquitin Transfer Pathway.ACS Chem Biol2019
29071405Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery.Adv Biochem Eng Biotechnol2018
29467494Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels.Oncogene2018
28829439An integrated expression atlas of miRNAs and their promoters in human and mouse.Nat Biotechnol2017
28295307High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.J Pathol2017
27081631Transcriptional profiling of macrophage and tumor cell interactions in vitro.Genom Data2016
25776849Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer.Sci Rep2015
26251520Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.J Clin Pathol2015
26543299CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.Dis Markers2015
23243026Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.Cancer Res2013
24030898Steering target selectivity and potency by fragment-based de novo drug design.Angew Chem Int Ed Engl2013
22200615Inflammation-induced lymph node lymphangiogenesis is reversible.Am J Pathol2012
  • 1 - 22 of 22

Recommended Authors

Institute of Medical Genetics and Pathology.
Career Start Year 2014
Number of shared co-authors 0
Keenan Research Centre in the Li Ka Shing Knowledge Institute, St. Michael's Hospital
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Sungkyunkwan University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
University of California irvine
Career Start Year 2009
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
University of British Columbia
Career Start Year 2008
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
Career Start Year 2003
Number of shared co-authors 0
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
University of California Riverside
Career Start Year 1992
Number of shared co-authors 0
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 19
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 0
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Institute of Pharmaceutical Sciences, ETH Zurich
Co-authored papers 9
Co-authored papers 5
Genome Institute of Singapore (GIS)
Co-authored papers 3
RIKEN Center for Integrative Medical Sciences
Co-authored papers 2
Co-authored papers 2
University of Helsinki
Co-authored papers 2
Kyungpook National University, Kyungpook National University Hospital
Co-authored papers 1
Vavilov Institute of General Genetics, Russian Academy of Sciences
Co-authored papers 1
Child and Family Research Institute, University of British Columbia
Co-authored papers 1
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 1
University Hospital Zurich
Co-authored papers 1
Co-authored papers 1
RIKEN Center for Life Science Technologies
Co-authored papers 1
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
Harry Perkins Institute of Medical Research
Co-authored papers 1
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
Ohu University School of Pharmaceutical Sciences
Co-authored papers 1
School of Pharmacy, Tokyo University of Pharmacy & Life Sciences
Co-authored papers 1
Cerevance Ltd
Co-authored papers 1
Research Center of Biotechnology RAS, Russian Academy of Sciences
Co-authored papers 1
Mater Research Institute-University of Queensland, Translational Research Institute
Co-authored papers 1
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
RIKEN Center for Integrative Medical Sciences
Co-authored papers 1
Institute of Industrial Science, The University of Tokyo
Co-authored papers 1
University of Copenhagen
Co-authored papers 1
RIKEN Center for Life Science Technologies
Co-authored papers 1
University Bordeaux, CNRS
Co-authored papers 1
Institute of Industrial Science, The University of Tokyo
Co-authored papers 1
University of Oslo
Co-authored papers 1